Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation.
Silva, LM; Lum, AG; Tran, C; Shaw, MW; Gao, Z; Flick, MJ; Moutsopoulos, NM; Bugge, TH; Mullins, ES.
Blood.
2019;
134:291-303.
Abnormal Uterine Bleeding in Adolescent Women.
Mullins, ES; Miller, RJ; Mullins, TL K.
Current Pediatrics Reports.
2018;
6:123-131.
Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A.
Dunn, AL; Ahuja, SP; Mullins, ES.
Haemophilia.
2018;
24:e84-e92.
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.
Shaw, MA; Gao, Z; McElhinney, KE; Thornton, S; Flick, MJ; Lane, A; Degen, JL; Ryu, JK; Akassoglou, K; Mullins, ES.
The Journal of neuroscience : the official journal of the Society for Neuroscience.
2017;
37:3776-3788.
Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A.
Mullins, ES; Stasyshyn, O; Alvarez-Roman, MT; Osman, D; Liesner, R; Engl, W; Sharkhawy, M; Abbuehl, BE.
Haemophilia.
2017;
23:238-246.
Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice.
Shaw, MA; Kombrinck, KW; McElhinney, KE; Sweet, DR; Flick, MJ; Palumbo, JS; Cheng, M; Esmon, NL; Esmon, CT; Brill, A; et al.
Blood.
2016;
128:721-731.
Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.
Arumugam, PI; Mullins, ES; Shanmukhappa, SK; Monia, BP; Loberg, A; Shaw, MA; Rizvi, T; Wansapura, J; Degen, JL; Malik, P.
Blood.
2015;
126:1844-1855.
Evaluation and Management of Adolescents with Abnormal Uterine Bleeding.
Mullins, TL K; Miller, RJ; Mullins, ES.
Pediatric Annals: a journal of continuing pediatric education.
2015;
44:e218-e222.
Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain.
Mullins, ES; Kombrinck, KW; Talmage, KE; Shaw, MA; Witte, DP; Ullman, JM; Degen, SJ; Sun, W; Flick, MJ; Degen, JL.
Blood.
2009;
113:696-704.
The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.
Srivaths, L; Minard, CG; O'Brien, SH; Wheeler, AP; Mullins, E; Sharma, M; Sidonio, R; Jain, S; Zia, A; Ragni, MV; et al.
Blood Advances.
2020;
4:3209-3216.